Combined alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, and aspartate aminotransferase to platelet ratio index for early hepatocellular carcinoma screening in hepatitis B cirrhosis
American Journal of Cancer Research · 2026 · 16 (10) · 4306-4318
DOI: 10.62347/lhsh3548 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Aifang Hou.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hou, A. (2026). Combined alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, and aspartate aminotransferase to platelet ratio index for early hepatocellular carcinoma screening in hepatitis B cirrhosis. American Journal of Cancer Research, 16(10), 4306-4318. https://doi.org/10.62347/lhsh3548
Vancouver
Hou A. Combined alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, and aspartate aminotransferase to platelet ratio index for early hepatocellular carcinoma screening in hepatitis B cirrhosis. American Journal of Cancer Research. 2026;16(10):4306-4318. doi:10.62347/lhsh3548
BibTeX
@article{Hou2026,
author = {Hou, Aifang},
title = {Combined alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, and aspartate aminotransferase to platelet ratio index for early hepatocellular carcinoma screening in hepatitis B cirrhosis},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {10},
pages = {4306--4318},
doi = {10.62347/lhsh3548}
}
EUVIMED